Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Conditions:   Primary Central Nervous System Lymphoma;   Secondary Central Nervous System Lymphoma;   Relapsed Cancer;   Refractory Cancer Interventions:   Drug: Pemetrexed;   Drug: Zanubrutinib;   Procedure: Autologous Stem Cell Transplant (ASCT);   Radiation: Whole Brain Radiation Therapy (WBRT) Sponsors:   Baptist Health South Florida;   BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials